共 50 条
- [21] Superior HbA1c Reduction with Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) Alone or with Oral Antihyperglycemic Medications (OAMs) in T2D Patients (Pts) Previously Treated with Basal Insulin: IMAGINE 5DIABETES, 2015, 64 : A249 - A250Buse, John B.Rodbard, Helena W.Serrano, Carlos TrescoliLuo, JunxiangIvanyi, TiborBue-Valleskey, JulianaHartman, Mark L.Carey, Michelle A.Chang, Annette M.
- [22] PERIPHERAL AND HEPATIC INSULIN SENSITIVITY IN HEALTHY ELDERLY HUMAN-SUBJECTSEUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (01) : 13 - 21BROUGHTON, DLJAMES, OWFALBERTI, KGMMTAYLOR, R
- [23] Metabolic effects of im vs. sc injection of soluble insulin and insulin lispro in healthy subjectsDIABETOLOGIA, 1998, 41 : A248 - A248Herrnberger, JHeise, TRave, KBender, RHirschberger, SHeinemann, L
- [24] Superior Reduction of HbA1c in a Double-Blind, Randomized Study of Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) in Patients (pts) with T1D: IMAGINEDIABETES, 2015, 64 : A250 - A250Bergenstal, Richard M.Lunt, HelenFranek, EdwardTravert, FlorenceMou, JianiHartman, Mark L.Rosilio, MyriamBastyr, Edward J., III
- [25] A Novel Insulin Lispro Formulation Containing Citrate and Treprostinil Demonstrates Faster Absorption and Onset of Insulin Action in Healthy SubjectsDIABETES, 2017, 66 : A253 - A253Leohr, JenniferPratt, Edward JohnHeilmann, CoryJohnson, JasonKelly, Ronan P.Lanschulz, William
- [26] Double Dose (DD) of Basal Insulin Peglispro (BIL) vs. Glargine (GL) Results in Markedly Lower Incidence of Hypoglycemia in Patients with T2D: IMAGINE 8DIABETES, 2016, 65 : A241 - A241Harris, Cynthia J.Forst, ThomasHeise, TimPlum-Morschel, LeonaWatkins, ElaineFan, LudiGarhyan, ParagPorksen, Niels K.
- [27] Greater HbA1c Reduction with Basal Insulin Peglispro (BIL) vs. Insulin Glargine (GL) in an Open-Label, Randomized Study in T1D Patients (pts): IMAGINE 1DIABETES, 2015, 64 : A25 - A25Garg, Satish K.Jinnouchi, HideakiDreyer, ManfredMou, JianiHartman, Mark L.Rosilio, MyriamBastyr, Edward J., III
- [28] Health Status in People With Type 2 Diabetes on Basal-Oral Therapy is Significantly Improved With Insulin Degludec vs. Insulin GlargineDIABETES, 2012, 61 : A313 - A313Freemantle, NickMeneghini, LuigiChristensen, Torsten E.Wolden, MichaelJendle, JohanRatner, Robert E.
- [29] Prandial insulin substitution with insulin lispro or insulin lispro, mid mixture vs. basal therapy with insulin glargine:: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapyJOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (03) : 145 - 152Kazda, CHülstrunk, HHelsberg, KLanger, FForst, THanefeld, M
- [30] Improved real-world outcomes for type 2 diabetes patients on basal-bolus insulin therapy switching to insulin glargine 300 U/ml vs. insulin glargine 100 U/ml and insulin DetemirPHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 416 - 417Wu, JasmandaBailey, Timothy S.Bosnyak, ZsoltWesterbacka, JukkaGupta, Rishab A.Menon, Arjun A.Nicholls, CharlieBlonde, Lawrence